Natur International Corp.
Healthcare · Services-Home Health Care Services · WY · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7M | $3.6M | $3.8M | $4.0M | $3.8M | $4.4M |
| Operating income | −$5.5M | −$288,826 | −$393,055 | −$160,990 | −$533,583 | −$115,223 |
| Net income | −$7.0M | −$380,559 | −$283,673 | −$249,319 | −$1.6M | −$19,138 |
| Total assets | $1.6M | $590,046 | $740,539 | $1.1M | $1.2M | $2.3M |
| Total liabilities | $19.0M | $1.7M | $1.5M | $1.6M | $1.5M | $1.0M |
| Equity | −$17.3M | −$1.1M | −$747,792 | −$464,119 | −$256,826 | $1.3M |
| EPS (diluted) | $-0.06 | $-0.08 | — | — | — | — |
| Shares out. | 11.3M | 11.3M | 11.3M | 10.7M | 10.2M | 10.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −329.0%
- Net margin
- −420.8%
- Return on equity
- 40.7%
- Return on assets
- −429.2%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 1155.4%
- Debt / equity
- —
- Book value / share
- $-1.54
- Revenue growth (YoY)
- −53.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -140.25distress
- Accruals / assets
- −107.0%clean
- Beneish M-Score
- -10.44normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.